Formulation and In vitro Evaluation of Gastroretentive Floating Bioadhesive Tablets of Nizatidine using Factorial Design

Q2 Pharmacology, Toxicology and Pharmaceutics
V. Sabale, Hardikkumar Chaudhari, P. Sabale
{"title":"Formulation and In vitro Evaluation of Gastroretentive Floating Bioadhesive Tablets of Nizatidine using Factorial Design","authors":"V. Sabale, Hardikkumar Chaudhari, P. Sabale","doi":"10.2174/2210303109666190221155353","DOIUrl":null,"url":null,"abstract":"\n\nThe aim of the present study was to formulate and evaluate floating bioadhesive\ntablets of Nizatidine which is a competitive, reversible H2-receptor antagonist. Floatingbioadhesive\ndrug delivery system exhibiting a unique combination of floatation and bioadhesion to prolong\ngastric residence time was prepared.\n\n\n\nPolymers used were Hydroxy Propyl Methyl Cellulose (HPMC) K15M as matrix forming\nwater swellable release retarding polymer and carbopol 934P as bioadhesive polymer. The gas generating\nagents used were sodium bicarbonate and citric acid. The prepared floating bioadhesive tablets of\nNizatidine were optimized by 32 factorial design to study independent variable X1 (concentration of CP\n934P) and X2 (concentration of HPMC K15M) and dependent variables as floating lag time, cumulative\npercentage drug release at 12h and swelling index. Tablets were evaluated for various parameters\nsuch as hardness, friability, drug content, swelling behavior, floating lag time, bioadhesive strength,\ndrug release profile and stability.\n\n\n\nAll the formulations passed the test for weight variation, hardness, content uniformity and\nshowed acceptable results with respect to drug content (97.93 ± 0.57) and % friability. The tablet containing\n25% HPMC K15M and 13.75 % Carbopol 934P was selected as optimized formulation which\nshowed the floating lag time of 74.34±2.08 seconds, drug release of 97.03±0.55% at 12 h (R12h,%), S.I\nas 79.24±0.87 at 9 h and bioadhesive strength as 10.0023±21.47 g. Stability of the formulation was\nproved using stability study.\n\n\n\nThe formulated tablets have a potential for controlled release of the drug through floatation\nand bioadhesion.\n","PeriodicalId":11310,"journal":{"name":"Drug Delivery Letters","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Delivery Letters","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2210303109666190221155353","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

The aim of the present study was to formulate and evaluate floating bioadhesive tablets of Nizatidine which is a competitive, reversible H2-receptor antagonist. Floatingbioadhesive drug delivery system exhibiting a unique combination of floatation and bioadhesion to prolong gastric residence time was prepared. Polymers used were Hydroxy Propyl Methyl Cellulose (HPMC) K15M as matrix forming water swellable release retarding polymer and carbopol 934P as bioadhesive polymer. The gas generating agents used were sodium bicarbonate and citric acid. The prepared floating bioadhesive tablets of Nizatidine were optimized by 32 factorial design to study independent variable X1 (concentration of CP 934P) and X2 (concentration of HPMC K15M) and dependent variables as floating lag time, cumulative percentage drug release at 12h and swelling index. Tablets were evaluated for various parameters such as hardness, friability, drug content, swelling behavior, floating lag time, bioadhesive strength, drug release profile and stability. All the formulations passed the test for weight variation, hardness, content uniformity and showed acceptable results with respect to drug content (97.93 ± 0.57) and % friability. The tablet containing 25% HPMC K15M and 13.75 % Carbopol 934P was selected as optimized formulation which showed the floating lag time of 74.34±2.08 seconds, drug release of 97.03±0.55% at 12 h (R12h,%), S.I as 79.24±0.87 at 9 h and bioadhesive strength as 10.0023±21.47 g. Stability of the formulation was proved using stability study. The formulated tablets have a potential for controlled release of the drug through floatation and bioadhesion.
尼扎替丁胃保留漂浮生物黏合剂的处方及体外因子评价
尼扎替丁是一种竞争性的、可逆的h2受体拮抗剂,本研究的目的是研制和评价尼扎替丁漂浮生物黏附片。制备了漂浮型生物黏附给药系统,该系统具有独特的漂浮与生物黏附相结合,可延长胃停留时间。高分子材料采用羟丙基甲基纤维素(HPMC) K15M为基质形成聚合物,卡波醇934P为生物黏附聚合物。使用的气体发生剂是碳酸氢钠和柠檬酸。采用32因子设计优化制备的尼扎替丁漂浮生物黏附片,考察自变量X1 (CP934P浓度)和X2 (HPMC K15M浓度),因变量为漂浮滞后时间、12h累积释药率和溶肿指数。对其硬度、脆度、药物含量、溶胀行为、漂浮滞后时间、生物黏附强度、药物释放谱和稳定性等进行评价。所有制剂均通过重量变异、硬度、含量均匀性试验,药物含量(97.93±0.57)和%脆性均可接受。以含25% HPMC K15M和13.75%卡波波尔934P的片剂为优化处方,其漂浮滞后时间为74.34±2.08 s, 12h释药率为97.03±0.55% (r12,%), 9 h释药率为79.24±0.87,生物黏附强度为10.0023±21.47 g。通过稳定性研究证明了该制剂的稳定性。该制剂具有通过漂浮和生物黏附控制药物释放的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug Delivery Letters
Drug Delivery Letters Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
CiteScore
1.70
自引率
0.00%
发文量
30
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信